Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2009

Mar 16, 2009

35119_dirs_2009-03-16_b22854e4-bde8-4b58-ac5b-d0c35e3fb834.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2009-03-10

Reporting Person: Lapointe Gregg Anthony (Director)